BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT)

CUSIP: G1125A108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / CL A SHS
Total 13F shares
13,085,561
Share change
+5,473,175
Total reported value
$126,532,000
Price per share
$9.67
Number of holders
50
Value change
+$52,904,156
Number of buys
33
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP G1125A108?
CUSIP G1125A108 identifies BIOT - BIOTECH ACQUISITION COMPANY - CL A SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) as of Q2 2021

As of 30 Jun 2021, BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,085,561 shares. The largest 10 holders included Corbin Capital Partners, L.P., CITADEL ADVISORS LLC, Periscope Capital Inc., Linden Advisors LP, Polar Asset Management Partners Inc., MMCAP International Inc. SPC, Saba Capital Management, L.P., Atalaya Capital Management LP, Blackstone Inc, and DG Capital Management, LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.